C

Creyos

Web-based brain health assessment platform

Cybersecurity Analyst

Full-Time
CA$80k - CA$100k/yr
Mid
Bachelor's
Toronto, ON, Canada
In Person
CybersecuritySecurity Operations & Incident Response, Security Governance, Risk & Compliance

About the job

Requirements
  • 1–3 years of professional work experience in information security.
  • Working knowledge of JIRA and Confluence.
  • Understanding of least privilege, access control, incident handling, and asset lifecycle management.
  • Ability to configure, implement, and maintain security tools and configure data sources for metric reporting and tracking.
  • Experience with security tools and methodologies for vulnerability and application security assessments.
  • Ability to analyze IT solutions and technology infrastructure to identify and assess security vulnerabilities, threats, and risks.
  • Understanding of industry frameworks such as NIST, SOC 2, or similar compliance frameworks.
  • Ability to serve as the accountable on-site cybersecurity resource.
  • Ability to analyze and synthesize technical information from various sources.
  • Ability to handle confidential matters professionally and exercise sound judgment and maturity.
  • Solid understanding of IT, network, and security environments.
  • Desire to learn compliance and security operations as a whole.
  • Verbal and written communication and relationship-building skills.
Responsibilities
  • Perform vulnerability and risk assessments and control testing across applications, networks, and infrastructure to remediate vulnerabilities and support secure software deployments.
  • Lead initial triage, resolution, and escalation for security incidents and support requests while monitoring advisories, alerts, and regulatory changes.
  • Conduct physical and technical security assessments, lead audit evidence collection and inquiries, and deliver remediation reports to key stakeholders.
  • Develop, recommend, and maintain security policies, standard operating procedures, and operational runbooks.
  • Administer end-to-end identity lifecycles, including provisioning, offboarding, and role-based access control based on least-privilege principles.
  • Maintain complete oversight and lifecycle inventory of hardware assets.
  • Deliver security-focused on-site IT support, including network hardening, hardware setup, account provisioning, and troubleshooting.
  • Mentor team members and promote internal knowledge sharing through technical presentations and documentation.
Desired Qualifications
  • Familiarity with endpoint management and mobile device management tools.
  • Working knowledge of governance, risk, and compliance tools.
  • A security-related professional qualification, such as CompTIA Network+, CompTIA Security+, or GCIH.
  • Bachelor’s degree in a technology-related field, or equivalent work experience.
  • Strong knowledge of operating system security and operations.
  • Strong, structured coding and scripting skills.
  • Knowledge of code repositories, automation technologies, cloud, and containers.

About the company

Creyos provides a web-based platform for cognitive health assessments with two main products: Creyos Health for clinicians and Creyos Research for researchers. Users complete brief online cognitive tasks that test memory, attention, reasoning, and verbal ability, and the platform then generates a scientifically validated report stored in the cloud. It differentiates itself through clinically validated cognitive metrics, scalable online administration, and a large global normative database used by leading clinics and researchers. The goal is to help health care providers monitor brain health over time and give researchers scalable, reliable cognitive data for studies, approvals, and wellness programs.

Company Size

51-200

Company Stage

Debt Financing

Total Funding

$1.5M

Headquarters

Canada

Founded

2014

Get referred to Creyos

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 Claremedica detected 90% of dementia cases after adopting Creyos.
  • July 2026 AAIC presentations expanded Creyos into dementia tracking and firefighter brain-health research.
  • May 2025 Redox integration now reaches ninety-plus EHRs, easing enterprise rollout.

What critics are saying

  • 86% specificity still creates false positives, triggering costly follow-up and clinician distrust.
  • Epic, Oracle Health, and other EHR vendors can bundle native cognitive screening fast.
  • If dementia claims disappoint in routine care, Creyos becomes a narrow research tool.

What makes Creyos unique

  • Creyos combines 400-plus studies with 85,000-plus norms and 20 million completions.
  • April 2026 Western University study hit 100% sensitivity and 86% specificity in six minutes.
  • FDA Class II registration and Redox integration anchor Creyos inside clinical workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Mental Health Support
  • Wellness Program
  • Paid Vacation
  • Paid Holidays
  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

4%

1 year growth

4%

2 year growth

4%
PR Newswire
Apr 8th, 2026
Creyos digital screener detects Alzheimer's with 100% sensitivity in 6 minutes

Creyos, a digital cognitive health assessment company, has published peer-reviewed research in the Journal of Alzheimer's Disease validating its two-task digital screener for dementia detection. The study, conducted by Western University researchers, found the screener achieved 100% sensitivity and 86% specificity in detecting Alzheimer's disease in approximately six minutes. The screener uses two tasks from Creyos's platform—a visuospatial working memory task and an attention task—analysed through machine learning models trained on data from over 20 million task completions. Researchers validated the system against datasets comprising 9,350 individuals aged 21 to 97. The screener outperformed the traditional Mini-Mental State Examination, correctly identifying one Alzheimer's patient who scored above MMSE's impairment threshold. Results remained consistent across gender, education level and study populations, with outcomes specifically identifying dementia-related impairment rather than other health conditions.

Creyos
Mar 3rd, 2026
AI, Digital Adoption, and Wearable Tech: Key Insights from NPA 2026

AI, digital adoption, and wearable tech: key insights from NPA 2026. Table Of Contents Creyos was a proud attendee of the 2026 NPA Psychopharmacology Update in Las Vegas, Nevada, from February 11 to 14, 2026. While this year's conference could be attended either online or in person, its team was too excited to attend from home and made the trek to sunny Nevada for the one-of-a-kind four-day event. The NPA Psychopharmacology Update is one of the largest psychopharmacology conferences in the US and has hosted over 2,000 attendees from all 50 states in addition to attendees from around the world. This conference presents a unique opportunity to engage in four days of impactful discussions and insightful lectures from internationally esteemed mental healthcare professionals. Those in attendance had the privilege of exploring new approaches to treatments and listening to enlightened debates on the latest ethics and legal implications of evolving technology - all through dynamic presentations. | Key Takeaways: * AI is continuing to climb in the healthcare industry * Digital adoption requires both legal and ethical considerations * ADHD treatments are evolving * Wearable tech might have a future for depression treatment | The event was the perfect opportunity to discuss the future of mental health care with psychiatrists, nurse practitioners, physician assistants, primary care physicians, and other mental health professionals. NPA 2026 offered all of its various exhibitors and sponsors a can't-miss opportunity to connect with key decision-makers and industry leaders to explore cutting-edge solutions in mental healthcare treatment. It is no wonder that the conference's audience was so engaged, as this opportunity to forge meaningful relationships and work towards a brighter future was like none other. Some Key Event Highlights In addition to meeting with a variety of incredibly well-informed professionals from across the mental health field, the Creyos team also attended an array of incredibly insightful talks and roundtables throughout the week. A few of its favorite discussions from this year's lineup included: AI, Almighty and Inevitable: The use of AI in Medical Practice This top-of-mind topic was tackled by Dr. Andrew Nanton, MD, on February 11. AI is continuing its climb in healthcare, and as adoption grows, more and more providers are exploring how AI can benefit their practices and their patients. The Cyber-Boundaries of Digital Professionalism: Avoiding Legal & Ethical Dangers Digital technology has the power to transform, but it can also open the door to potential legal and ethical issues. Dr. James Knoll, MD, hosted this fantastic talk on February 11 about how providers can ensure they are protected legally and approach integration with the best possible intentions as digital technology becomes an increasingly important part of running a modern medical practice. ADHD: Treatment Updates Dr. James McGough, MD, hosted this fantastic talk on February 13 about how ADHD treatments are evolving. For years, providers have noted that ADHD cases are on the rise as awareness about the condition grows. But alongside this growing demand is an evolving treatment landscape. As awareness of ADHD grows and changes with new technology and research, so too do treatment recommendations. Use of Wearable Technologies in the Treatment of Depression Hosted by Paola Pedrelli, MD, on February 14, this discussion centered around the adoption of wearable technologies for the treatment of depression. Creyos is always keen to learn more about new technologies in the medical world and explore the latest ways in which patients with potentially critical cognitive conditions can be aided through advancements in tech. If you want to learn more about some of the critical insights Creyos heard at the 2026 NPA Psychopharmacology Update in Las Vegas, reach out and connect with one of its team members. The Future of Mental Health Care With so many esteemed professionals focused on advancing treatments and so carefully considering the potential impact of any changes they make, NPA 2026 made it clear that the future of mental healthcare is in good hands - and that future looks bright. Advancing technology has the potential to revolutionize the way Creyos approach mental healthcare assessment and treatment monitoring. In particular, digital cognitive testing like that from Creyos gives providers objective insights that make diagnostic processes easier and more streamlined. This leads to quicker, more confident clinical decision-making and faster access to treatment for patients. This testing also allows for longitudinal testing, making it ideal for treatment monitoring and ongoing assessment. In clinical practice, assessments can provide mental healthcare professionals with objective measurements to better understand how conditions like ADHD, depression, anxiety, or other mental health conditions are impacting their cognition. Importantly, these tests are also made with privacy in mind and are completely HIPAA compliant so that providers can assess patients knowing their private healthcare information is safe. If you're looking to advance your mental health assessment with digital cognitive testing, reach out to learn more about how comprehensive digital cognitive assessments can help bring your practice into the future. Measure the Cognitive Impact of Anxiety Backed by over 30 years of research, Creyos is here to help you confidently measure cognitive markers of anxiety to deliver better patient outcomes, faster. Talk to an Expert Join thousands of healthcare professionals who receive a monthly update on the latest research and news in brain health.

Wealth Creation Investing, LLC
Sep 30th, 2025
Creyos Recognized as Quarterfinalist for the 2025 Digital Health Hub Foundation: Digital Health Awards

TORONTO, Sept. 30, 2025 /PRNewswire/ - Creyos, the digital platform reshaping brain health assessment in clinical care, is thrilled to announce its selection as a quarterfinalist for the prestigious 2025 Digital Health Hub Foundation: Digital Health Awards.

Health Technology Insights
May 13th, 2025
Creyos Partners with Redox to Eliminate Barriers to Cognitive Health Data in EHRs

Creyos partners with Redox to eliminate barriers to cognitive health data in EHRs.

HIT Consultant
May 13th, 2025
Creyos, Redox Partner To Integrate Cognitive Assessments Into Ehrs

What You Should Know:– Creyos, an online platform for objective cognitive and behavioral health assessments, today announced a strategic partnership with Redox, a prominent provider of healthcare data interoperability solutions.– The collaboration is set to enable large health systems and integrated delivery networks to seamlessly embed Creyos’ validated cognitive testing tools directly into their existing electronic health records (EHRs), effectively dismantling one of the most significant barriers to scaling proactive brain health care.The Growing Imperative for Proactive Brain HealthThe need for accessible and efficient cognitive assessment tools is becoming increasingly critical. With over 55 million people worldwide currently living with dementia—a figure projected to soar to 139 million by 2050—early and accurate screening is paramount. Such screenings enable timely intervention, personalized care planning, and ultimately, improved patient outcomes. As healthcare systems increasingly shift towards value-based care models, Creyos is focused on helping providers integrate cognitive health as a core component of routine and preventive care, utilizing tools that are both clinically proven and straightforward to implement.Overcoming Implementation Hurdles with Seamless IntegrationA common challenge for new health technologies is gaining traction within large health systems, often due to poor alignment with existing clinical workflows and complex integration processes. This new Creyos-Redox partnership directly addresses these issues. By leveraging Redox’s expansive EHR network, which supports interoperability across more than 90 EHR systems including major platforms like Cerner, eClinicalWorks, and Allscripts, Creyos can deliver seamless data integration and platform access